日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GMP-Compliant Process for the Manufacturing of an Extracellular Vesicles-Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial.

符合 GMP 标准的工艺,用于生产源自心血管祖细胞的富含细胞外囊泡的分泌组产品,适用于 I 期临床试验

Humbert Camille, Cordier Chloé, Drut Iouri, Hamrick Michele, Wong Jacquelyn, Bellamy Valérie, Flaire Justine, Bakshy Kiranmayee, Dingli Florent, Loew Damarys, Larghero Jérôme, Fabreguettes Jean-Roch, Menasché Philippe, Renault Nisa K, Churlaud Guillaume

First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report

心血管细胞来源分泌组在心力衰竭中的首次人体应用:病例报告

Menasché, Philippe; Renault, Nisa K; Hagège, Albert; Puscas, Tania; Bellamy, Valérie; Humbert, Camille; Le, Laetitia; Blons, Hélène; Granier, Clémence; Benhamouda, Nadine; Bacher, Anne; Churlaud, Guillaume; Sabatier, Brigitte; Larghero, Jérôme